NATURAL ALTERNATIVES INTERNATIONAL INC Deferred Income Tax Assets, Net
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) had Deferred Income Tax Assets, Net of $0 as of 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2025-09-23
- 2025-06-30: Deferred Income Tax Assets, Net $0.00.
- 2025-03-31: Deferred Income Tax Assets, Net $3.24M.
- 2024-12-31: Deferred Income Tax Assets, Net $3.13M.
- 2024-09-30: Deferred Income Tax Assets, Net $3.33M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2025-06-30 | $0.00 10-K · filed 2025-09-23 |
| 2025-03-31 | $3.24M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $3.13M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $3.33M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $3.17M 10-K · filed 2025-09-23 |
| 2024-03-31 | $291.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $321.00K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $161.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $355.00K 10-K · filed 2024-09-27 |
| 2022-06-30 | $0.00 10-K · filed 2023-09-21 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 |
| 2021-12-31 | $0.00 10-Q · filed 2022-02-09 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $214.00K 10-K · filed 2022-09-21 |
| 2021-03-31 | $680.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.26M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $1.00M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $196.00K 10-K · filed 2021-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |